These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Screening for cervical neoplasia. A survey of the assumptions from studies on the screening in Maribo Amt. Berget A. Dan Med Bull; 1979 Nov; 26(7):313-32. PubMed ID: 118850 [No Abstract] [Full Text] [Related]
7. Screening for uterine cancer in Iceland. Thorarinsson A, Jensson O, Bjarnason O. Acta Cytol; 1969 May; 13(5):304-8. PubMed ID: 5256946 [No Abstract] [Full Text] [Related]
9. [Mortality from cancer of the uterine cervix in Denmark 1961-71]. Grünfeld K, Horwitz O, Lysgaard-Hansen B. Ugeskr Laeger; 1975 Jan 27; 137(5):251-9. PubMed ID: 1136032 [No Abstract] [Full Text] [Related]
15. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria. Vutuc C, Haidinger G, Waldhoer T, Ahmad F, Breitenecker G. Wien Klin Wochenschr; 1999 May 07; 111(9):354-9. PubMed ID: 10407996 [Abstract] [Full Text] [Related]
16. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer]. Jensen ML, Dybdahl H, Svanholm H. Ugeskr Laeger; 2000 May 22; 162(21):3024-7. PubMed ID: 10850190 [Abstract] [Full Text] [Related]
20. Cost effectiveness of population screening and rescreening for cervical cancer in the Netherlands. Boon ME, de Graaff Guilloud JC. Acta Cytol; 1981 May 22; 25(5):539-42. PubMed ID: 6792845 [Abstract] [Full Text] [Related] Page: [Next] [New Search]